NYSE: CCChemours Co Stock Ownership - Who owns Chemours Co?
Insider buying vs selling
Have Chemours Co insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Calderon Gerardo Familiar | Pres | 2026-08-12 | 1,935 | $15.53 | $30.05kBuy |
| David Will | CAO | 2026-08-12 | 2,426 | $15.24 | $36.97kSell |
| Denise Dignam | CEO | 2026-08-11 | 3,378 | $14.95 | $50.50kBuy |
| Alister Cowan | Director | 2026-08-07 | 13,000 | $15.62 | $203.06kBuy |
| Mary B. Cranston | Director | 2026-08-07 | 6,000 | $15.83 | $94.95kBuy |
| Michael Robert Foley | Pres | 2026-08-07 | 1,934 | $15.51 | $30.00kBuy |
| Joseph T. Martinko | Pres | 2026-08-07 | 1,939 | $15.47 | $30.00kBuy |
| Shane Hostetter | CFO | 2026-08-06 | 3,087 | $15.11 | $46.64kSell |
| Shane Hostetter | CFO | 2026-08-06 | 3,350 | $14.94 | $50.05kBuy |
| Calderon Gerardo Familiar | Pres | 2026-08-01 | 943 | $16.61 | $15.66kSell |
CC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CC insiders and whales buy or sell their stock.
CC Shareholders
What type of owners hold Chemours Co stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Mark P. Vergnano | 0.57% | 858,692 | $12.31M | Insider |
| Sameer Ralhan | 0.25% | 381,345 | $5.47M | Insider |
| Denise Dignam | 0.23% | 339,916 | $4.87M | Insider |
| Mark Newman | 0.20% | 304,069 | $4.36M | Insider |
| David C. Shelton | 0.14% | 215,109 | $3.08M | Insider |
| Thierry Fj Vanlancker | 0.13% | 190,022 | $2.72M | Insider |
| E. Bryan Snell | 0.10% | 146,983 | $2.11M | Insider |
| Edwin C. Sparks | 0.09% | 137,243 | $1.97M | Insider |
| Damian Gumpel | 0.09% | 131,701 | $1.89M | Insider |
| Mary B. Cranston | 0.08% | 113,140 | $1.62M | Insider |
CC vs Specialty Chemical Stocks
Chemours Co Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.